688658 悦康药业
已收盘 02-25 15:00:00
资讯
新帖
简况
悦康药业:控股股东持有的172万股公司股份将被司法拍卖
每日经济新闻 · 02-25 21:20
悦康药业:控股股东持有的172万股公司股份将被司法拍卖
悦康药业(688658)披露董事、高级管理人员离任暨补选职工董事公告,2月24日股价下跌0.43%
证券之星 · 02-24 18:26
悦康药业(688658)披露董事、高级管理人员离任暨补选职工董事公告,2月24日股价下跌0.43%
每周股票复盘:悦康药业(688658)董事及高管人事变动
证券之星 · 02-15
每周股票复盘:悦康药业(688658)董事及高管人事变动
每周股票复盘:悦康药业(688658)2026年首次临时股东会通过关联交易议案
证券之星 · 02-08
每周股票复盘:悦康药业(688658)2026年首次临时股东会通过关联交易议案
悦康药业(688658)披露2026年第一次临时股东会决议公告,2月6日股价上涨0.73%
证券之星 · 02-06
悦康药业(688658)披露2026年第一次临时股东会决议公告,2月6日股价上涨0.73%
2月2日悦康药业跌9.07%,富国精准医疗混合A基金重仓该股
证券之星 · 02-02
2月2日悦康药业跌9.07%,富国精准医疗混合A基金重仓该股
悦康药业(688658.SH)发预亏,预计2025年年度归母净亏损2.35亿元至2.8亿元
智通财经 · 01-30
悦康药业(688658.SH)发预亏,预计2025年年度归母净亏损2.35亿元至2.8亿元
增长失速、盈利触底 悦康药业(688658.SH)赴港为求“续命”?
智通财经 · 01-28
增长失速、盈利触底 悦康药业(688658.SH)赴港为求“续命”?
每周股票复盘:悦康药业(688658)预计2026年日常关联交易24,156万元
证券之星 · 01-25
每周股票复盘:悦康药业(688658)预计2026年日常关联交易24,156万元
业绩连续三年下滑 悦康药业(688658.SH)“救火式”赴港上市?
智通财经 · 01-23
业绩连续三年下滑 悦康药业(688658.SH)“救火式”赴港上市?
1月19日悦康药业跌5.21%,富国精准医疗混合A基金重仓该股
证券之星 · 01-19
1月19日悦康药业跌5.21%,富国精准医疗混合A基金重仓该股
悦康药业筹划H股上市:新增长叙事挑战重重 左手募资右手大额分红前次募投项目多次延期
新浪证券 · 01-16
悦康药业筹划H股上市:新增长叙事挑战重重 左手募资右手大额分红前次募投项目多次延期
1月9日悦康药业涨17.13%,富国精准医疗混合A基金重仓该股
中金财经 · 01-09
1月9日悦康药业涨17.13%,富国精准医疗混合A基金重仓该股
悦康药业(688658.SH)营收净利三连降 于伟仕家族为何还分红超4亿?
智通财经 · 01-08
悦康药业(688658.SH)营收净利三连降 于伟仕家族为何还分红超4亿?
每周股票复盘:悦康药业(688658)递交H股上市申请
证券之星 · 01-02
每周股票复盘:悦康药业(688658)递交H股上市申请
悦康药业向港交所提交上市申请
第一财经 · 2025-12-29
悦康药业向港交所提交上市申请
每周股票复盘:悦康药业(688658)拟发行H股赴港上市
证券之星 · 2025-12-28
每周股票复盘:悦康药业(688658)拟发行H股赴港上市
悦康药业(688658)披露拟发行H股并在港交所上市,12月22日股价上涨2.75%
证券之星 · 2025-12-22
悦康药业(688658)披露拟发行H股并在港交所上市,12月22日股价上涨2.75%
悦康药业(688658.SH):子公司YKYY032注射液获国家药品监督管理局和FDA临床试验批准
智通财经 · 2025-12-19
悦康药业(688658.SH):子公司YKYY032注射液获国家药品监督管理局和FDA临床试验批准
悦康药业,爆亏1.5亿却要赴港上市,开源证券预测明年还是亏损?
市场资讯 · 2025-12-19
悦康药业,爆亏1.5亿却要赴港上市,开源证券预测明年还是亏损?
公司概况
公司名称:
悦康药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2020-12-24
主营业务:
悦康药业集团股份有限公司的主营业务是原料药及制剂相关产品的生产和销售。公司的主要产品是银杏叶提取物注射液、天麻素注射液、注射用兰索拉唑、奥美拉唑肠溶胶囊、盐酸二甲双胍缓释片、注射用头孢呋辛钠、注射用头孢曲松钠。公司连续多年荣获工信部医药工业百强和中国医药研发产品线最佳工业企业的殊荣,入榜《2025年中国药品研发综合实力排行榜TOP100》并荣登《2025中国中药研发实力排行榜》第六名。2024年,公司“头孢菌素类抗生素原料药关键技术研究及产业化应用”项目,荣获河南省科学技术进步三等奖,彰显了公司在医药领域的卓越成就和创新实力。
发行价格:
24.36
{"stockData":{"symbol":"688658","market":"SH","secType":"STK","nameCN":"悦康药业","latestPrice":21.27,"timestamp":1772002800000,"preClose":21,"halted":0,"volume":5311241,"delay":0,"changeRate":0.0129,"floatShares":450000000,"shares":450000000,"eps":-0.52,"marketStatus":"已收盘","change":0.27,"latestTime":"02-25 15:00:00","open":21,"high":21.44,"low":20.92,"amount":112000000,"amplitude":0.0248,"askPrice":21.27,"askSize":82,"bidPrice":21.26,"bidSize":27,"shortable":0,"etf":0,"ttmEps":-0.52,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772069400000},"marketStatusCode":5,"adr":0,"adjPreClose":21,"symbolType":"stock_kcb","openAndCloseTimeList":[[1771983000000,1771990200000],[1771995600000,1772002800000]],"highLimit":23.1,"lowLimit":18.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":450000000,"isCdr":false,"pbRate":2.79,"roa":"--","roe":"--","epsLYR":0.28,"committee":0.047244,"marketValue":9572000000,"turnoverRate":0.0118,"status":0,"afterMarket":{"amount":0,"volume":0,"close":21.27,"buyVolume":0,"sellVolume":0,"time":1772004837558,"indexStatus":"已收盘 02-25 15:30:00","preClose":21},"floatMarketCap":9572000000},"requestUrl":"/m/hq/s/688658/wiki","defaultTab":"wiki","newsList":[{"id":"2614708066","title":"悦康药业:控股股东持有的172万股公司股份将被司法拍卖","url":"https://stock-news.laohu8.com/highlight/detail?id=2614708066","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614708066?lang=zh_cn&edition=full","pubTime":"2026-02-25 21:20","pubTimestamp":1772025600,"startTime":"0","endTime":"0","summary":"每经AI快讯,2月25日,悦康药业公告,控股股东阜阳京悦永顺信息咨询有限公司持有的本公司172万股无限售流通股股票将被司法拍卖。该事项不会影响公司控制权稳定,亦不会对公司日常经营管理造成影响。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-02-25/doc-inhnzvzk2137962.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-25/doc-inhnzvzk2137962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2613040792","title":"悦康药业(688658)披露董事、高级管理人员离任暨补选职工董事公告,2月24日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613040792","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613040792?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:26","pubTimestamp":1771928776,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘,悦康药业报收于21.0元,较前一交易日下跌0.43%,最新总市值为94.5亿元。悦康药业集团股份有限公司近日发布《关于公司董事、高级管理人员离任暨补选职工董事的公告》。公告显示,公司董事会于近日收到职工代表董事张伟先生、副总经理杨磊先生的书面辞任报告。杨磊先生已当选为公司第三届董事会职工代表董事,任期自2026年2月13日起至本届董事会任期届满。上述人员变动不影响公司董事会正常运作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2611145858","title":"每周股票复盘:悦康药业(688658)董事及高管人事变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2611145858","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611145858?lang=zh_cn&edition=full","pubTime":"2026-02-15 01:48","pubTimestamp":1771091292,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘,悦康药业报收于21.09元,较上周的22.2元下跌5.0%。本周,悦康药业2月10日盘中最高价报23.6元。公司公告汇总悦康药业集团股份有限公司董事会于近日收到职工代表董事张伟先生、副总经理杨磊先生的书面辞任报告。杨磊先生已当选为公司第三届董事会职工代表董事,任期自2026年2月13日起至本届董事会任期届满。上述人员变动不影响公司董事会正常运作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2609452623","title":"每周股票复盘:悦康药业(688658)2026年首次临时股东会通过关联交易议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2609452623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609452623?lang=zh_cn&edition=full","pubTime":"2026-02-08 03:15","pubTimestamp":1770491713,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,悦康药业报收于22.2元,较上周的24.26元下跌8.49%。本周关注点公司公告汇总:2026年第一次临时股东会审议通过《关于公司2026年度日常关联交易预计的议案》,表决权占比18.5704%。公司公告汇总悦康药业集团股份有限公司于2026年2月6日召开2026年第一次临时股东会,会议由董事会召集,董事长于伟仕主持,采用现场与网络投票相结合方式表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2609883594","title":"悦康药业(688658)披露2026年第一次临时股东会决议公告,2月6日股价上涨0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609883594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609883594?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:26","pubTimestamp":1770387983,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,悦康药业报收于22.2元,较前一交易日上涨0.73%,最新总市值为99.9亿元。近日,悦康药业集团股份有限公司披露《2026年第一次临时股东会决议公告》。公告显示,公司于2026年2月6日召开2026年第一次临时股东会,会议由董事会召集,董事长于伟仕主持,采用现场与网络投票相结合方式表决。出席会议的股东及代理人共222人,代表有表决权股份82,542,058股,占公司总表决权比例18.5704%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600041112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2608485190","title":"2月2日悦康药业跌9.07%,富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608485190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608485190?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:45","pubTimestamp":1770021951,"startTime":"0","endTime":"0","summary":"证券之星消息,2月2日悦康药业跌9.07%,收盘报22.06元,换手率3.31%,成交量14.88万手,成交额3.39亿元。重仓悦康药业的前十大公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共23家,其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.77亿元,最新净值2.987,较上一交易日上涨0.91%,近一年上涨35.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2607019142","title":"悦康药业(688658.SH)发预亏,预计2025年年度归母净亏损2.35亿元至2.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607019142","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607019142?lang=zh_cn&edition=full","pubTime":"2026-01-30 18:27","pubTimestamp":1769768838,"startTime":"0","endTime":"0","summary":"智通财经APP讯,悦康药业(688658.SH)发布2025年年度业绩预亏公告,预计2025年年度实现归属于母公司所有者的净利润为-28,000万元到-23,500万元,与上年同期(法定披露数据)相比,将出现亏损。公司2024年末对产品“银杏叶提取物注射液”价格及销售策略进行调整,该事项对公司收入和利润呈现阶段性较大的影响。公司坚持长期发展战略,不断调整和完善经营策略,提升运营效率,同时逐步优化销售策略,维护核心销售渠道的稳定,持续增强公司核心竞争力和投资价值。报告期内,公司继续保持高比例研发投入,研发费用同比上升,高比例的研发投入对公司净利润产生了一定影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"悦康药业(688658.SH)发预亏,预计2025年年度归母净亏损2.35亿元至2.8亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2606766618","title":"增长失速、盈利触底 悦康药业(688658.SH)赴港为求“续命”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2606766618","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606766618?lang=zh_cn&edition=full","pubTime":"2026-01-28 11:38","pubTimestamp":1769571493,"startTime":"0","endTime":"0","summary":"2026年1月初,科创板上市的化学药企悦康药业集团股份有限公司,已正式向港交所递交了H股上市申请。公司营收已连续三年下滑,从2022年的45.42亿元降至2024年的37.81亿元。2025年一季度的亏损表明,阵痛远未结束。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2606373062","title":"每周股票复盘:悦康药业(688658)预计2026年日常关联交易24,156万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606373062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606373062?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:32","pubTimestamp":1769283132,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,悦康药业报收于27.15元,较上周的28.59元下跌5.04%。本周,悦康药业1月21日盘中最高价报28.68元。本周关注点公司公告汇总:预计2026年度日常关联交易总额为24,156.00万元。会议将审议《关于公司2026年度日常关联交易预计的议案》,该议案需对中小投资者单独计票,并实行关联股东回避表决。公司预计2026年度日常关联交易总额为24,156.00万元,涵盖向关联方采购原材料、商品、接受服务、销售产品以及房产租赁等事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2605042024","title":"业绩连续三年下滑 悦康药业(688658.SH)“救火式”赴港上市?","url":"https://stock-news.laohu8.com/highlight/detail?id=2605042024","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605042024?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:25","pubTimestamp":1769156754,"startTime":"0","endTime":"0","summary":"近日,悦康药业发布公告称,为进一步提高公司综合竞争力,提升公司国际品牌形象,同时更好地利用国际资本市场,多元化融资渠道,公司拟在境外发行股份(H股)并在港交所主板上市。2020年12月24日,悦康药业在上海证券交易所科创板上市。事实上,近年来悦康药业业绩已连续三年下滑。2025年,悦康药业业绩进一步下滑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2604185930","title":"1月19日悦康药业跌5.21%,富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604185930","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604185930?lang=zh_cn&edition=full","pubTime":"2026-01-19 15:37","pubTimestamp":1768808230,"startTime":"0","endTime":"0","summary":"证券之星消息,1月19日悦康药业跌5.21%,收盘报27.1元,换手率1.86%,成交量8.37万手,成交额2.29亿元。重仓悦康药业的前十大公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共21家,其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为34.91亿元,最新净值3.2156,较上一交易日下跌0.93%,近一年上涨49.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900014458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2603968033","title":"悦康药业筹划H股上市:新增长叙事挑战重重 左手募资右手大额分红前次募投项目多次延期","url":"https://stock-news.laohu8.com/highlight/detail?id=2603968033","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603968033?lang=zh_cn&edition=full","pubTime":"2026-01-16 15:43","pubTimestamp":1768549380,"startTime":"0","endTime":"0","summary":" 在登陆上海证券交易所科创板不足五年之际,悦康药业于近期发布公告称计划发行境外上市外资股(H股)并在香港联合交易所有限公司主板上市。公司表示,此举旨在进一步提升综合竞争力与国际品牌形象,并拓展国际资本市场融资渠道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-01-16/doc-inhhnuux3992775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2602328172","title":"1月9日悦康药业涨17.13%,富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602328172","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602328172?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:53","pubTimestamp":1767945234,"startTime":"0","endTime":"0","summary":"证券之星消息,1月9日悦康药业涨17.13%创60日新高,收盘报31.79元,换手率4.45%,成交量20.04万手,成交额5.86亿元。重仓悦康药业的前十大公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共21家,其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为34.91亿元,最新净值3.2598,较上一交易日下跌0.01%,近一年上涨53.84%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/09/20260109981127.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/09/20260109981127.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260109/31929452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2601354509","title":"悦康药业(688658.SH)营收净利三连降 于伟仕家族为何还分红超4亿?","url":"https://stock-news.laohu8.com/highlight/detail?id=2601354509","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601354509?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:52","pubTimestamp":1767862357,"startTime":"0","endTime":"0","summary":"港股生物医药板块迎来久违的上涨行情。百济神州、翰森制药等龙头股价节节攀升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688658"],"gpt_icon":0},{"id":"2600036316","title":"每周股票复盘:悦康药业(688658)递交H股上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036316?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:43","pubTimestamp":1767292989,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,悦康药业报收于23.13元,较上周的22.52元上涨2.71%。本周,悦康药业12月25日盘中最高价报24.07元。悦康药业当前最新总市值101.75亿元,在化学制药板块市值排名52/150,在两市A股市值排名1883/5181。本周关注点公司公告汇总:悦康药业已向香港联交所递交H股发行上市申请,并刊发申请资料。本次发行上市尚需取得中国证监会、香港证监会、香港联交所等监管机构的批准或核准,存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2595735465","title":"悦康药业向港交所提交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2595735465","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595735465?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:11","pubTimestamp":1767017460,"startTime":"0","endTime":"0","summary":"据港交所文件,悦康药业集团股份有限公司向港交所提交上市申请书,独家保荐人为中信证券。(本文来自第一财经)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-12-29/doc-inhenrqi0053490.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-29/doc-inhenrqi0053490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","HEXmain","688658"],"gpt_icon":0},{"id":"2594247827","title":"每周股票复盘:悦康药业(688658)拟发行H股赴港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247827?lang=zh_cn&edition=full","pubTime":"2025-12-28 04:48","pubTimestamp":1766868489,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,悦康药业报收于23.13元,较上周的22.52元上涨2.71%。本周,悦康药业12月25日盘中最高价报24.07元。本周关注点公司公告汇总:悦康药业拟发行H股股票并在香港联交所上市。公司公告汇总:悦康药业2025年第三次临时股东会出席股东代表股份占比53.6184%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2593351084","title":"悦康药业(688658)披露拟发行H股并在港交所上市,12月22日股价上涨2.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593351084","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593351084?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:52","pubTimestamp":1766415132,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘,悦康药业报收于23.14元,较前一交易日上涨2.75%,最新总市值为104.13亿元。该股当日开盘22.99元,最高23.72元,最低22.43元,成交额达1.2亿元,换手率为1.15%。会议表决方式符合法律规定,议案均获通过,无被否决议案。中小投资者对部分议案进行了单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200035587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["HEXmain","BK0239","688658"],"gpt_icon":0},{"id":"2592152396","title":"悦康药业(688658.SH):子公司YKYY032注射液获国家药品监督管理局和FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2592152396","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592152396?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:39","pubTimestamp":1766133582,"startTime":"0","endTime":"0","summary":"智通财经APP讯,悦康药业 发布公告,公司子公司北京悦康科创医药科技股份有限公司、杭州天龙药业有限公司于近日获得国家药品监督管理局核准签发的关于YKYY032注射液用于治疗高脂蛋白血症的《药物临床试验批准通知书》。YKYY032注射液是一款偶联N-乙酰半乳糖胺配体的化学合成双链siRNA药物,通过RNA干扰机制特异性沉默LPA基因转录的mRNA,从源头阻断脂蛋白[Lp]生成,拟用于高脂蛋白血症治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"悦康药业(688658.SH):子公司YKYY032注射液获国家药品监督管理局和FDA临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2592713549","title":"悦康药业,爆亏1.5亿却要赴港上市,开源证券预测明年还是亏损?","url":"https://stock-news.laohu8.com/highlight/detail?id=2592713549","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592713549?lang=zh_cn&edition=full","pubTime":"2025-12-19 06:58","pubTimestamp":1766098680,"startTime":"0","endTime":"0","summary":" 最近,科创板上市公司悦康药业正在紧锣密鼓地策划发行H股、赴港上市,目前已经聘请容诚(香港)会计师事务所有限公司作为专项审计机构。 也就是说,就连一贯以乐观预期为标签、且持续给出悦康药业买入评级的开源证券,都认为公司在2026年不大可能实现盈利了,仍将出现大额亏损。在这样的背景下,悦康药业还要赴港上市、更好地利用国际资本市场?","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-19/doc-inhchsqr6018516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","BK0239","688658"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772058338635,"stockEarnings":[{"period":"1week","weight":0.0085},{"period":"1month","weight":-0.2093},{"period":"3month","weight":-0.1385},{"period":"6month","weight":-0.2274},{"period":"1year","weight":0.3361},{"period":"ytd","weight":-0.0593}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0035},{"period":"3month","weight":0.0702},{"period":"6month","weight":0.075},{"period":"1year","weight":0.2394},{"period":"ytd","weight":0.0449}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"悦康药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"10690人(较上一季度减少8.39%)","perCapita":"42095股","listingDate":"2020-12-24","address":"北京市大兴区北京经济技术开发区宏达中路6号","registeredCapital":"45000万元","survey":" 悦康药业集团股份有限公司的主营业务是原料药及制剂相关产品的生产和销售。公司的主要产品是银杏叶提取物注射液、天麻素注射液、注射用兰索拉唑、奥美拉唑肠溶胶囊、盐酸二甲双胍缓释片、注射用头孢呋辛钠、注射用头孢曲松钠。公司连续多年荣获工信部医药工业百强和中国医药研发产品线最佳工业企业的殊荣,入榜《2025年中国药品研发综合实力排行榜TOP100》并荣登《2025中国中药研发实力排行榜》第六名。2024年,公司“头孢菌素类抗生素原料药关键技术研究及产业化应用”项目,荣获河南省科学技术进步三等奖,彰显了公司在医药领域的卓越成就和创新实力。","listedPrice":24.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"悦康药业(688658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供悦康药业(688658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"悦康药业,688658,悦康药业股票,悦康药业股票老虎,悦康药业股票老虎国际,悦康药业行情,悦康药业股票行情,悦康药业股价,悦康药业股市,悦康药业股票价格,悦康药业股票交易,悦康药业股票购买,悦康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"悦康药业(688658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供悦康药业(688658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}